NicholasKianMollanazarMDMBA

Assistant Professor of Clinical Dermatology

Dr. Mollanazar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Boulevard
South Pavilion 1st floor,
Philadelphia, PA 19104
Phone+1 215-662-2737

PubMed

Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2).
Gil Yosipovitch, Brian S Kim, Shawn G Kwatra, Nicholas K Mollanazar, Sonja Ständer
JAAD International. 2024-09-01
Dupilumab for the treatment of pityriasis lichenoides chronica.
Charissa N Obeng-Nyarko, Kevin Puerta Durango, Shanelle Jackson, Olaf Rodriguez, Nicholas K Mollanazar
JAAD Case Reports. 2024-08-01
7 citations
Chronic Pruritus: A Review.
Daniel C Butler, Timothy Berger, Sarina Elmariah, Brian Kim, Sarah Chisolm
JAMA. 2024-06-25

Journal Articles

Reduced Itch Associated with Dupilumab Treatment in 4 Patients with Prurigo Nodularis
Nicholas K Mollanazar, May Elgash, Sylvia Hsu, JAMA
Epidemiology of Chronic Pruritus: Where Have We Been and Where Are We Going?
Nicholas K. Mollanazar, Savannah Dean Koch, Gil Yosipovitch, Current Dermatology Reports

Looking Forward: Maximizing Efficiency from Electronic Health RecordsApril 3rd, 2023